These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The TLR9 Antagonist iCpG-ODN at Different Dosages Inhibits Cerebral Ischemia/Reperfusion Injury in Mice. Zhou Y; Pan J; Peng Q; Dong Z; Deng L; Wang Y CNS Neurol Disord Drug Targets; 2017; 16(5):624-633. PubMed ID: 28176622 [TBL] [Abstract][Full Text] [Related]
9. CpG postconditioning after reperfused myocardial infarction is associated with modulated inflammation, less apoptosis, and better left ventricular function. Duerr GD; Wu S; Schneider ML; Marggraf V; Weisheit CK; Velten M; Verfuerth L; Frede S; Boehm O; Treede H; Dewald O; Baumgarten G; Kim SC Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H995-H1007. PubMed ID: 32857588 [TBL] [Abstract][Full Text] [Related]
10. Synthetic Human TLR9-LRR11 Peptide Attenuates TLR9 Signaling by Binding to and thus Decreasing Internalization of CpG Oligodeoxynucleotides. Pan X; Li B; Kuang M; Liu X; Cen Y; Qin R; Ding G; Zheng J; Zhou H Int J Mol Sci; 2016 Feb; 17(2):242. PubMed ID: 26907260 [TBL] [Abstract][Full Text] [Related]
11. The Toll-like receptor 9 ligand, CpG oligodeoxynucleotide, attenuates cardiac dysfunction in polymicrobial sepsis, involving activation of both phosphoinositide 3 kinase/Akt and extracellular-signal-related kinase signaling. Gao M; Ha T; Zhang X; Wang X; Liu L; Kalbfleisch J; Singh K; Williams D; Li C J Infect Dis; 2013 May; 207(9):1471-9. PubMed ID: 23359590 [TBL] [Abstract][Full Text] [Related]
12. CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3K/Akt signaling. Cao Z; Ren D; Ha T; Liu L; Wang X; Kalbfleisch J; Gao X; Kao R; Williams D; Li C Biochim Biophys Acta; 2013 Jan; 1832(1):96-104. PubMed ID: 22917564 [TBL] [Abstract][Full Text] [Related]
13. The toll-like receptor 9 agonist, CpG-oligodeoxynucleotide 1826, ameliorates cardiac dysfunction after trauma-hemorrhage. Zhang X; Gao M; Ha T; Kalbfleisch JH; Williams DL; Li C; Kao RL Shock; 2012 Aug; 38(2):146-52. PubMed ID: 22576005 [TBL] [Abstract][Full Text] [Related]
14. Cpg-ODN, a TLR9 Agonist, Aggravates Myocardial Ischemia/Reperfusion Injury by Activation of TLR9-P38 MAPK Signaling. Xie L; He S; Kong N; Zhu Y; Tang Y; Li J; Liu Z; Liu J; Gong J Cell Physiol Biochem; 2018; 47(4):1389-1398. PubMed ID: 29929196 [TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 9 promotes cardiac inflammation and heart failure during polymicrobial sepsis. Lohner R; Schwederski M; Narath C; Klein J; Duerr GD; Torno A; Knuefermann P; Hoeft A; Baumgarten G; Meyer R; Boehm O Mediators Inflamm; 2013; 2013():261049. PubMed ID: 23935245 [TBL] [Abstract][Full Text] [Related]
16. Intra-Peritoneal Administration of Mitochondrial DNA Provokes Acute Lung Injury and Systemic Inflammation via Toll-Like Receptor 9. Zhang L; Deng S; Zhao S; Ai Y; Zhang L; Pan P; Su X; Tan H; Wu D Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589725 [TBL] [Abstract][Full Text] [Related]
17. Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury. Yasuda H; Leelahavanichkul A; Tsunoda S; Dear JW; Takahashi Y; Ito S; Hu X; Zhou H; Doi K; Childs R; Klinman DM; Yuen PS; Star RA Am J Physiol Renal Physiol; 2008 May; 294(5):F1050-8. PubMed ID: 18305095 [TBL] [Abstract][Full Text] [Related]
19. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer]. Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109 [TBL] [Abstract][Full Text] [Related]
20. Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells. He W; Zhang Y; Zhang J; Yu Q; Wang P; Wang Z; Smith AJ J Endod; 2012 Jun; 38(6):780-5. PubMed ID: 22595112 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]